King Faisal Specialist Hospital & Research Centre; Oncology
Riyadh, Saudi Arabia
Hospital in Riyadh
طريق مكة المكرمة الفرعي،، Al Mathar Ash Shamali, Riyadh 11564
About King Faisal Specialist Hospital & Research Centre; Oncology
The King Faisal Specialist Hospital and Research Centre is tertiary referral hospital in Riyadh, the capital city of Saudi Arabia.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
4
King Faisal Specialist Hospital & Research Center
2
Clinical Trials at King Faisal Specialist Hospital & Research Centre; Oncology
During the past decade, King Faisal Specialist Hospital & Research Centre; Oncology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on
average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
2009-04-11
2014-11-18
Completed
1,842
A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer
2012-06-01
2019-09-20
Completed
1,436
Combined Alternating Sunitinib and Bevacizumab (Avastin®) in Advanced Renal Cell Carcinoma (CASA)
2014-12-01
2021-12-01
Unknown status
77
Neo-adjuvant Chemoradiotherapy Using Infusional Gemcitabine Followed by Surgery for Locally Advanced Rectal Cancer
2014-12-01
2019-12-01
Unknown status
25
A Study of Atezolizumab in Locally Advanced or Metastatic Urothelial or Non-Urothelial Carcinoma of the Urinary Tract
2016-11-30
2022-12-12
Completed
1,005
A Study to Evaluate the Safety and Tolerability of Prophylactic Emicizumab in Hemophilia A Patients With Inhibitors
2017-09-05
2020-11-19
Completed
195
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at King Faisal Specialist Hospital & Research Centre; Oncology
According to Clinical.Site data, the most researched conditions in "King Faisal Specialist Hospital & Research Centre; Oncology" are
"Breast Neoplasms" (1 trials), "Hemophilia A" (1 trials), "Hepatitis B, Chronic" (1 trials), "Rectal Adenocarcinoma" (1 trials) and "Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "King Faisal Specialist Hospital & Research Centre; Oncology" in a lesser frequency.
Clinical Trials Intervention Types at King Faisal Specialist Hospital & Research Centre; Oncology
Most popular intervention types in "King Faisal Specialist Hospital & Research Centre; Oncology" are "Drug" (5 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (1 trials), "Bevacizumab" (1 trials), "Docetaxel" (1 trials), "Emicizumab" (1 trials) and "Gemcitabine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at King Faisal Specialist Hospital & Research Centre; Oncology
The vast majority of trials in "King Faisal Specialist Hospital & Research Centre; Oncology" are
6 trials for "All" genders.
Clinical Trials Status at King Faisal Specialist Hospital & Research Centre; Oncology
Currently, there are NaN active trials in "King Faisal Specialist Hospital & Research Centre; Oncology".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in King Faisal Specialist Hospital & Research Centre; Oncology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in King Faisal Specialist Hospital & Research Centre; Oncology, 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".